Glycemic Management

In a small study of patients with type 1 diabetes using an automated insulin delivery system, semaglutide improved glucose control vs. placebo, researchers reported at the European Association for the Study of Diabetes Annual Meeting.

Adults with type 2 diabetes at high risk for cardiovascular events were more likely to sustain an HbA1c of 6.5% or less at 2 years with tirzepatide if they lost more weight and had improved beta-cell function, according to new data.

Pregnant women with diabetes can use automated insulin delivery systems with settings optimized to achieve tight glycemic targets, according to two speakers at the Association of Diabetes Care and Education Specialists annual meeting.

A majority of people with diabetes rely on their primary care provider for diabetes management and believe using drugs such as GLP-1 receptor agonists are enough to manage their disease, according to survey results.

A voluntary medical device correction has been issued for a small number of continuous glucose monitoring sensors distributed in the first half of May, according to an industry press release.

The FDA declined to approve once-weekly basal insulin icodec for the treatment of diabetes and is requesting more information from Novo Nordisk, according to a company press release.

Circulating levels of some microRNA species may predict response to diabetes treatment and changes in beta-cell function among children and adolescents with type 2 diabetes, according to findings from the TODAY study.

ORLANDO — Since 2005, an Irish diabetes in pregnancy program has steadily improved pregnancy and neonatal outcomes through extensive research and development of services for care before, during and after pregnancy.

ORLANDO — Adding continuous glucose monitoring to hospital standard of care does not appear to improve glycemic control for adults with type 2 diabetes, according to results of the TIGHT study.